SEC Form 4 · accession 0001209191-18-047884
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alison Cecily Finger
Officer — Chief Commercial Officer
Period of report
Aug 20, 2018
Accepted (ET)
Aug 22, 2018 · 6:32 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 20, 2018 | S | 159 | $158.05 | D | 15,767 | D | |
| Common StockF1,F2 | Aug 20, 2018 | S | 100 | $158.10 | D | 15,667 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
- F2Includes 87 shares that were acquired by the Reporting Person under the bluebird bio, Inc. employee stock purchase plan on July 31, 2018.